Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Protara Therapeutics, Inc. | VP, Controller | Common Stock | 29.8K | $57K | $1.91 | Jan 19, 2024 | Direct |
Protara Therapeutics, Inc. | VP, Controller | Stock Option (Right to Buy) | 46K | Jan 19, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TARA | Protara Therapeutics, Inc. | Jan 19, 2024 | 3 | -$1.73K | 4 | Jan 23, 2024 | VP, Controller |
TARA | Protara Therapeutics, Inc. | Jan 3, 2024 | 1 | -$703 | 4 | Jan 5, 2024 | VP, Controller |
TARA | Protara Therapeutics, Inc. | Jul 17, 2023 | 1 | -$25.8K | 4 | Jul 18, 2023 | VP, Controller |
TARA | Protara Therapeutics, Inc. | Jan 19, 2023 | 2 | $0 | 4 | Jan 20, 2023 | VP, Controller |
TARA | Protara Therapeutics, Inc. | Jan 3, 2023 | 1 | -$1.01K | 4 | Jan 4, 2023 | VP, Controller |
TARA | Protara Therapeutics, Inc. | Jul 16, 2022 | 1 | $0 | 4 | Jul 19, 2022 | VP, Controller |
TARA | Protara Therapeutics, Inc. | Jul 16, 2022 | 0 | $0 | 3 | Jul 19, 2022 | VP, Controller |